Efficacy of IV Lidocaine at Alleviating Pain Associated With Propofol Infusion in Pediatric Patients Undergoing Sedation
Completed · Phase 4 · Has a placebo group
Conditions studied: Pain
In brief
This protocol describes a double-blind, placebo-controlled trial intended to demonstrate the effectiveness of lidocaine at reducing pain associated wiht propofol infusion for short-term deep sedation in children. Patients will be randomized to receive either placebo (saline) or one of two dosing regimens of IV lidocaine prior to initiating propofol infusion. The efficacy of the differing lidocaine doses will be compared to determine the minimum dose required to safely achieve alleviation of pain. We hypothesize that premedicating with lidocaine will significantly decrease pain experienced by pediatric patients receiving propofol for outpatient sedation.
Key facts
- Study ID
- NCT00786916
- Run by
- Akron Children's Hospital
- People needed
- 109
- Starts
- 2008-02-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2015-02-27
Who can join
Age: 2 and older, up to 7. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- scheduled for painless diagnostic procedures
- are ASA I or ASA II
You may not qualify if…
- have an indwelling central venous catheter
- have received an analgesic or sedative medication in the previous four hours prior to enrollment
- have an underlying chronic disorder that would impact on their ability to express distress when in painful or otherwise anxiety-provoking situations
- known hypersensitivity to lidocaine or any component of the formulation
- hypersensitivity to another local anesthetic of the amide type
- Adam-Stokes syndrome
- severe degrees of SA, AV, or intraventricular heart block
- allergy to corn-related products
- contraindication to propofol
Where it is running
- Akron Children's Hospital — Akron, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.